08045804946
Send Inquiry
LEUXA 11.25MG INJ
3000.0 INR/Number
Product Details:
- Dosage Form Parenteral (Injection)
- Origin of Medicine India
- Life Span Refer to expiry date on pack
- Indication Hormone-dependent cancers and related conditions
- Brand Name LEUXA
- Salt Composition Leuprolide Acetate 11.25 mg
- Packaging Type Vial and Ampoule in sealed pack
- Click to View more
X
LEUXA 11.25MG INJ Price And Quantity
- 3000.0 INR/Number
- 1 Number
- Yes
- Gonadotropin-releasing hormone (GnRH) analog
- 2 years from manufacturing date
- Hypersensitivity to Leuprolide, Pregnancy, Breastfeeding
- Intramuscular injection
- White or off-white lyophilized powder with diluent
- Single-use only
- To be reconstituted with supplied ampoule before injection
LEUXA 11.25MG INJ Product Specifications
- 1 Vial and 1 Ampoule
- Leuprolide Acetate 11.25 mg
- Vial and Ampoule in sealed pack
- Store below 25C. Do not freeze. Protect from light.
- Hormone therapy / LHRH Agonist
- Adults
- Prostate cancer, Endometriosis, Uterine fibroids, Precocious puberty, and as determined by physician
- Injection
- Refer to expiry date on pack
- Hormone-dependent cancers and related conditions
- LEUXA
- Administer under medical supervision as per prescribed regimen
- India
- 11.25 mg per injection, as prescribed by physician
- Parenteral (Injection)
- 1 Vial + 1 Ampoule
- Leuprolide Acetate (Leuprorelin Acetate)
- Allopathic
- Yes
- Gonadotropin-releasing hormone (GnRH) analog
- 2 years from manufacturing date
- Hypersensitivity to Leuprolide, Pregnancy, Breastfeeding
- Intramuscular injection
- White or off-white lyophilized powder with diluent
- Single-use only
- To be reconstituted with supplied ampoule before injection
LEUXA 11.25MG INJ Trade Information
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Leuprolide acetate (11.25 mg).
- Form: It is an injection (depot suspension) that is administered by a healthcare professional either under the skin (subcutaneously) or into a muscle (intramuscularly). The 11.25 mg dose is often a 3-month formulation.
- Mechanism of Action: It works by initially stimulating, then suppressing the production of hormones (testosterone in men, estrogen in women) produced by the body, which slows the growth of hormone-sensitive cells and tissues.
Uses
Leuxa 11.25 mg injection is used for treating several hormone-dependent conditions, including managing symptoms of advanced prostate cancer by lowering testosterone levels, which slows the growth of cancer cells. In women, it helps reduce estrogen production to relieve pain and other symptoms of endometriosis and to shrink uterine fibroids. It is also prescribed for children with precocious puberty to delay the process and allow for more normal growth. Additionally, it may be used in fertility treatments to control hormone levels.
Common Side Effects
Common side effects may include hot flashes, increased sweating, decreased libido, dizziness, headaches, nausea, vomiting, upset stomach, injection site reactions, fatigue, and muscle weakness. Long-term use can potentially lead to bone thinning (osteoporosis), and doctors might suggest calcium and vitamin D supplements.
Important Note: This information is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional for medical concerns or before starting any new medication.
How LEUXA 11.25MG INJ Works
LEUXA operates as a gonadotropin-releasing hormone (GnRH) analog. It acts by lowering certain hormone levels in the body, making it effective for treating hormone-dependent cancers and conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty. This mechanism helps control abnormal cell growth and manage related symptoms.
Safe and Supervised Administration
LEUXA 11.25MG INJ must be administered as an intramuscular injection by a qualified healthcare professional. The medication is supplied as a lyophilized powder, which should be reconstituted with the provided ampoule immediately before injection. Following prescribed dosage and medical supervision ensures efficacy and helps minimize adverse effects.
Usage, Storage, and Handling
This injection is designed for single-use only and is intended for adult patients unless prescribed otherwise for specific indications. LEUXA should be stored below 25C, away from light, and never frozen. Proper handling and storage are essential to maintain the medication's effectiveness and safety over its 2-year shelf life.
FAQ's of LEUXA 11.25MG INJ:
Q: How should LEUXA 11.25MG INJ be administered?
A: LEUXA 11.25MG INJ must be given as an intramuscular injection by a healthcare professional, under strictly supervised medical conditions. The powder should be reconstituted with the supplied ampoule just prior to use.Q: What conditions is LEUXA 11.25MG INJ prescribed for?
A: This medication is recommended for hormone-dependent conditions such as prostate cancer, endometriosis, uterine fibroids, precocious puberty, and other indications as determined by your physician.Q: When should LEUXA 11.25MG INJ not be used?
A: Do not use LEUXA if you have hypersensitivity to leuprolide or similar compounds, or if you are pregnant or breastfeeding. Patients should always discuss their medical history with their doctor before starting treatment.Q: Where should LEUXA 11.25MG INJ be stored?
A: Store the injection below 25C, in its original packaging to protect it from light. It should not be frozen. Always follow the storage guidance mentioned on the pack.Q: What are the necessary steps before administering the injection?
A: LEUXA comes as a lyophilized powder and must be reconstituted using the provided ampoule right before application. All preparation and administration steps should be completed by a qualified healthcare provider.Q: What are the key benefits of using LEUXA 11.25MG INJ?
A: LEUXA helps manage hormone-dependent malignancies and related disorders by regulating hormone levels, offering effective symptom control and improved quality of life when used as directed by your healthcare professional.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
